Evolution of angiotensin-converting enzyme inhibitors

Area of Science:

• Cardiovascular Endocrinology
• Pharmacology

Background:

• The renin-angiotensin system is crucial for blood pressure regulation.
• Angiotensin II, a potent vasoconstrictor, mediates this system's effects.
• Angiotensin-converting enzyme (ACE) is key in angiotensin II synthesis.

Purpose of the Study:

• To trace the historical development of ACE inhibitors.
• To highlight their therapeutic applications in cardiovascular diseases.

Main Methods:

• Review of historical research and drug development.
• Analysis of the biochemical pathway of angiotensin II biosynthesis.

Main Results:

• Early inhibitors were derived from snake venom peptides.
• Development led to effective drugs for hypertension and heart failure.

Conclusions:

• ACE inhibitors represent a significant advancement in managing cardiovascular conditions.
• The evolution of these inhibitors demonstrates successful drug discovery from natural sources.